We are live on ! Find out more
B

Bellecapital Portfolio holdings

AUM $554M
1-Year Est. Return 29.39%
This Fund
S&P 500
This Quarter Est. Return
+1.35%
1 Year Est. Return
+29.39%
3 Year Est. Return
+99.7%
5 Year Est. Return
+120.39%
10 Year Est. Return
+406.87%
AUM
$161M
AUM Growth
+$3.67M
Cap. Flow
+$2.82M
Cap. Flow %
1.75%
Top 10 Hldgs %
38.31%
Holding
133
New
17
Increased
38
Reduced
32
Closed
10

Top Buys

1
ALC icon
Alcon
ALC
+$3.13M
2
GLD icon
SPDR Gold Trust
GLD
+$1.27M
3
IBDO
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
+$763K
4
IBDM
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
+$757K
5
IBDN
iShares iBonds Dec 2022 Term Corporate ETF
IBDN
+$670K

Top Sells

1
JD icon
JD.com
JD
+$3.58M
2
MPC icon
Marathon Petroleum
MPC
+$696K
3
BMY icon
Bristol-Myers Squibb
BMY
+$690K
4
KR icon
Kroger
KR
+$657K
5
AMZN icon
Amazon
AMZN
+$434K

Sector Composition

1 Consumer Discretionary 13.43%
2 Technology 12.28%
3 Communication Services 10.77%
4 Healthcare 10.06%
5 Consumer Staples 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AXJL
101
DELISTED
WisdomTree Asia-Pacific ex-Japan Fund
AXJL
$273K 0.17%
4,004
– –
MRK icon
102
Merck
MRK
$315B
$270K 0.17%
3,380
+446
+15% +$34.1K
MKC icon
103
McCormick & Company Non-Voting
MKC
$14B
$268K 0.17%
+3,462
New +$267K
VGK icon
104
Vanguard FTSE Europe ETF
VGK
$30B
$253K 0.16%
4,600
– –
FEZ icon
105
State Street SPDR EURO STOXX 50 ETF
FEZ
$4.28B
$247K 0.15%
6,450
– –
AMGN icon
106
Amgen
AMGN
$196B
$245K 0.15%
1,329
+80
+6% +$14.3K
VGSH icon
107
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
$241K 0.15%
3,953
– –
WCG
108
DELISTED
Wellcare Health Plans, Inc.
WCG
$238K 0.15%
+835
New +$230K
KMB icon
109
Kimberly-Clark
KMB
$35.9B
$237K 0.15%
1,780
– –
BMY icon
110
Bristol-Myers Squibb
BMY
$124B
$228K 0.14%
5,023
-14,810
-75% -$690K
ECL icon
111
Ecolab
ECL
$76.7B
$217K 0.13%
+1,100
New +$205K
TCOM icon
112
Trip.com Group
TCOM
$26.7B
$215K 0.13%
+5,823
New +$230K
JNK icon
113
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$7.36B
$207K 0.13%
1,899
-1,221
-39% -$132K
QQQ icon
114
Invesco QQQ Trust
QQQ
$467B
$205K 0.13%
+1,100
New +$202K
IEI icon
115
iShares 3-7 Year Treasury Bond ETF
IEI
$18.2B
$204K 0.13%
1,623
– –
EW icon
116
Edwards Lifesciences
EW
$49.5B
$201K 0.13%
+3,270
New +$198K
IAU icon
117
iShares Gold Trust
IAU
$62.3B
$201K 0.13%
7,450
– –
CHI
118
Calamos Convertible Opportunities and Income Fund
CHI
$1.03B
$191K 0.12%
18,212
+412
+2% +$4.28K
ING icon
119
ING
ING
$92.4B
$175K 0.11%
15,150
– –
TEF
120
DELISTED
Telefonica
TEF
$149K 0.09%
22,277
– –
TEVA icon
121
Teva Pharmaceuticals
TEVA
$37.4B
$148K 0.09%
16,000
– –
SAN icon
122
Banco Santander
SAN
$193B
$137K 0.09%
31,311
– –
FCX icon
123
Freeport-McMoran
FCX
$84.3B
$125K 0.08%
10,765
– –
CLX icon
124
Clorox
CLX
$11.6B
– –
-1,781
Closed -$286K
DD icon
125
DuPont de Nemours
DD
$18.2B
– –
-2,518
Closed -$229K
2 3 4
5
6

Similar funds

LFS
Legacy Financial Strategies Overland Park, Kansas $554M AUM 16% 1-Year Est. Return
TC
Truvestments Capital Sarasota, Florida $554M AUM 32.49% 1-Year Est. Return
SIM
Studio Investment Management Chicago, Illinois $555M AUM 15.74% 1-Year Est. Return
AWA
ARQ Wealth Advisors Scottsdale, Arizona $555M AUM 17.82% 1-Year Est. Return
FFA
Founders Financial Alliance Raleigh, North Carolina $555M AUM 22.31% 1-Year Est. Return
CCA
Childress Capital Advisors Houston, Texas $555M AUM 27.99% 1-Year Est. Return
HWM
Heirloom Wealth Management Greenwood Village, Colorado $555M AUM 19.9% 1-Year Est. Return
TPA
Trivium Point Advisory Westport, Connecticut $553M AUM 26.47% 1-Year Est. Return

Bellecapital's Q2 2019 Portfolio in Review

As of Q2 2019, Bellecapital held 133 positions worth $161M, up 2.3% from $157M the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Bellecapital's Q2 2019 filing shows 17 new, 38 increased, 32 reduced and 10 closed positions. Its largest new stake was Alcon: 53,356 shares worth $3.29M. The largest sale was JD.com, an estimated $3.58M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 13% of assets, down from 16% a quarter earlier, followed by Technology and Communication Services.

  • Bellecapital's largest Q2 2019 buy was Alcon: 53,356 shares worth $3.29M.
  • Bellecapital added most to SPDR Gold Trust in Q2 2019, an estimated $1.27M increase.
  • Bellecapital's biggest Q2 2019 reduction was Bristol-Myers Squibb, cutting an estimated $690K.
  • Bellecapital fully exited JD.com in Q2 2019, selling an estimated $3.58M.
  • Bellecapital's ten largest holdings make up 38% of its $161M portfolio in Q2 2019.
  • Bellecapital opened 17 new positions and closed 10 in Q2 2019.
  • Bellecapital's portfolio value rose 2.3% quarter-over-quarter to $161M.

Based on Bellecapital's 13F filing for Q2 2019, filed 22 Jul 2019.